K2 Principal Fund’s Dimension Therapeutics, Inc DMTX Stock Holding History
Bought
Maintained
Sold
K2 Principal Fund's DMTX Position: Q4 2017 in Review
K2 Principal Fund sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2017, closing a stake of 160,000 shares — an estimated $960K sold.
K2 Principal Fund first reported a position in DMTX in Q3 2017 and held it in 1 quarter. The position peaked at $960K in Q3 2017. 0 funds tracked by Wall St. Rank hold DMTX as of Q4 2017.
- K2 Principal Fund reported no remaining Dimension Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
- K2 Principal Fund sold 160,000 Dimension Therapeutics, Inc shares in Q4 2017, an estimated $960K.
- K2 Principal Fund first reported a position in Dimension Therapeutics, Inc in Q3 2017 and held it in 1 quarter.
- K2 Principal Fund's Dimension Therapeutics, Inc position peaked at $960K in Q3 2017.
- 0 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2017.
Based on K2 Principal Fund's 13F filing for Q4 2017, filed 12 Feb 2018.